Organisation paid for research Program year 2025 Source: CMS Open Payments

Chicago Ent

Neither a doctor nor a teaching hospital

Research payments

$218,198

18 payments

Through program year 2025, Chicago Ent is reported as receiving $218,198 in research payments, across 18 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$22,654	2
2024	Research	$16,971	2
2023	Research	$31,377	2
2022	Research	$70,547	4
2021	Research	$16,143	4
2020	Research	$2,078	2
2019	Research	$58,428	2

Breakdown

Who paid Research payments · program years 2019–2025

AstraZeneca Pharmaceuticals LP $216,881 17 payments
LivaNova USA, Inc. $1,317 1 payment

Studies the money was for Research payments · program years 2019–2025

A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyposis WAYPOINT $131,397 7 payments
A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients with Severe Nasal Polyposis OSTRO $70,832 6 payments
A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler $10,152 3 payments
A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab for the Prevention of Recurrence of Nasal Polyps Following Surgical Removal in Patients with Chronic Rhinosinusitis with Nasal Polyps (OXALIS) $4,500 1 payment
Targeted Hypoglossal Neurostimulation Study #2 (THN2) $1,317 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.